Cargando…

Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg

BACKGROUND: A simple hysterectomy is considered the definitive treatment modality for cervical intraepithelial neoplasia (CIN). However, it is associated with recurrence of vaginal intraepithelial neoplasia (VAIN) of up to 7.4%. We sought to determine recurrence rates of VAIN, in women living with H...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbuyisa, Sanele S., Khumalo, Thandekile L., Makhathini, Bongumusa S., Moodley, Jagidesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991234/
https://www.ncbi.nlm.nih.gov/pubmed/35384680
http://dx.doi.org/10.4102/safp.v64i1.5457
_version_ 1784683535458631680
author Mbuyisa, Sanele S.
Khumalo, Thandekile L.
Makhathini, Bongumusa S.
Moodley, Jagidesa
author_facet Mbuyisa, Sanele S.
Khumalo, Thandekile L.
Makhathini, Bongumusa S.
Moodley, Jagidesa
author_sort Mbuyisa, Sanele S.
collection PubMed
description BACKGROUND: A simple hysterectomy is considered the definitive treatment modality for cervical intraepithelial neoplasia (CIN). However, it is associated with recurrence of vaginal intraepithelial neoplasia (VAIN) of up to 7.4%. We sought to determine recurrence rates of VAIN, in women living with HIV (WLWH) and non-infected women. METHODS: This was a descriptive retrospective review of patients who received a simple hysterectomy for CIN between January 2015 and December 2017 in Pietermaritzburg. RESULTS: Fifty-eight files were reviewed. Forty-two (72.4%) WLWH were seen; amongst those, 76.2% were virally suppressed. Abnormal vault cytology was only seen in patients with CIN grades 2 and 3. The recurrence rates for high-grade squamous intraepithelial lesion (HSIL) were 6.1% and 5.0% at 6 and 12 months, respectively. Human immunodeficiency virus co-infection was associated with 26.2% versus 13.3% of abnormal vault cytology compared to the HIV-negative counterparts (p = 0.164). Virologically suppressed patients had more abnormal cytology (28.1% vs. 0%) compared to the unsuppressed patients. There was a 17.2% and 65.5% loss- to follow-up rates at 6 and 12 months, respectively. Recurrence of premalignant lesions was noted amongst those who had the abdominal approach. CONCLUSION: The recurrence rates were comparable to the previous literature. A 6-month cytology follow-up showed no added benefit. Human immunodeficiency virus co-infection didn’t show a statistical significance on the recurrence rates; however, more structured studies are required to address this. Primary health care-based post operative surveillance can be a solution to address high loss to follow-up.
format Online
Article
Text
id pubmed-8991234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-89912342022-04-09 Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg Mbuyisa, Sanele S. Khumalo, Thandekile L. Makhathini, Bongumusa S. Moodley, Jagidesa S Afr Fam Pract (2004) Original Research BACKGROUND: A simple hysterectomy is considered the definitive treatment modality for cervical intraepithelial neoplasia (CIN). However, it is associated with recurrence of vaginal intraepithelial neoplasia (VAIN) of up to 7.4%. We sought to determine recurrence rates of VAIN, in women living with HIV (WLWH) and non-infected women. METHODS: This was a descriptive retrospective review of patients who received a simple hysterectomy for CIN between January 2015 and December 2017 in Pietermaritzburg. RESULTS: Fifty-eight files were reviewed. Forty-two (72.4%) WLWH were seen; amongst those, 76.2% were virally suppressed. Abnormal vault cytology was only seen in patients with CIN grades 2 and 3. The recurrence rates for high-grade squamous intraepithelial lesion (HSIL) were 6.1% and 5.0% at 6 and 12 months, respectively. Human immunodeficiency virus co-infection was associated with 26.2% versus 13.3% of abnormal vault cytology compared to the HIV-negative counterparts (p = 0.164). Virologically suppressed patients had more abnormal cytology (28.1% vs. 0%) compared to the unsuppressed patients. There was a 17.2% and 65.5% loss- to follow-up rates at 6 and 12 months, respectively. Recurrence of premalignant lesions was noted amongst those who had the abdominal approach. CONCLUSION: The recurrence rates were comparable to the previous literature. A 6-month cytology follow-up showed no added benefit. Human immunodeficiency virus co-infection didn’t show a statistical significance on the recurrence rates; however, more structured studies are required to address this. Primary health care-based post operative surveillance can be a solution to address high loss to follow-up. AOSIS 2022-03-31 /pmc/articles/PMC8991234/ /pubmed/35384680 http://dx.doi.org/10.4102/safp.v64i1.5457 Text en © 2022. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Mbuyisa, Sanele S.
Khumalo, Thandekile L.
Makhathini, Bongumusa S.
Moodley, Jagidesa
Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
title Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
title_full Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
title_fullStr Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
title_full_unstemmed Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
title_short Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
title_sort prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, pietermaritzburg
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991234/
https://www.ncbi.nlm.nih.gov/pubmed/35384680
http://dx.doi.org/10.4102/safp.v64i1.5457
work_keys_str_mv AT mbuyisasaneles prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg
AT khumalothandekilel prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg
AT makhathinibongumusas prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg
AT moodleyjagidesa prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg